Quantum Genomics (Alternext – FR0011648971 – ALQGC), a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, will be participating at the 15th edition of the European Large & Midcap Event, a conference dedicated to meetings between European listed companies and institutional investors, to be held in Paris on October 7 & 8, 2015.
[button link=”http://www.quantum-genomics.com/www/wp-content/uploads/2015/09/QGC_PR_MidCap-Event-10-2015_20150922_VersionFinale_UK.pdf” target=”_blank” title=”Download Press Release” size=”small” color=”red”]
